PCM
FMI

Prelude Capital Management’s Foundation Medicine, Inc. FMI Stock Holding History

Prelude Capital Management’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-44,800
Closed -$793K – 1940
2016
Q4 		$793K Buy
+44,800
New +$965K 0.1% 245
2016
Q1 		– Sell
-9,900
Closed -$208K – 1692
2015
Q4 		$208K Buy
+9,900
New +$191K 0.03% 550

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Prelude Capital Management's FMI Position: Q2 2015 in Review

Prelude Capital Management sold out of Foundation Medicine, Inc. (FMI) in Q2 2015, closing a stake of 3,500 shares — an estimated $168K sold.

Prelude Capital Management first reported a position in FMI in Q2 2014 and held it in 2 quarters. The position peaked at $168K in Q1 2015. 96 funds tracked by Wall St. Rank hold FMI as of Q2 2015.

  • Prelude Capital Management reported no remaining Foundation Medicine, Inc. position as of Q2 2015 after selling out during the quarter.
  • Prelude Capital Management sold 3,500 Foundation Medicine, Inc. shares in Q2 2015, an estimated $168K.
  • Prelude Capital Management first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 2 quarters.
  • Prelude Capital Management's Foundation Medicine, Inc. position peaked at $168K in Q1 2015.
  • 96 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2015.

Based on Prelude Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.